Keywords
Last Name
Institution

Raymond F Anton

TitleEndowed Chair, Strom Thurmond Wellness and fitness Endowed Chair
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
454N
67 President St.
Phone843-792-1226
Fax843-792-7353
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Anton is a Distinguished University Professor and senior investigator with over 25 years of research experience. He is considered an international expert in biologic markers of alcohol use as well as in new treatments for alcohol use disorders (AUD's), as evidenced by conducting over 15 clinical trials. He participated in PROJECT Match as well as being the chair of the COMBINE Study and first author of its publication in JAMA. His team also developed one of he first fMRI alcohol cue tasks showing activation in salient brain reward systems that could be blocked by medications. As a current holder of a Senior Scientist Career and Mentoring Award (K05) he has used that support to integrate genetics and neuroimaging into his clinical trial work. His group has begun to bring together the brain-imaging paradigm with genetics and pharmacogenetics, providing the best technology available to investigate alcohol effects on the human brain as they relate to alcoholism vulnerability and treatment.

    Collapse keywords
    Alcohol, Substance Use, Brain, Genetics, Stage II, Stage III, Drug Studies

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Prisciandaro JJ, Schacht JP, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton RF. Evidence for a unique association between fronto-cortical glycine levels and recent heavy drinking in treatment naïve individuals with alcohol use disorder. Neurosci Lett. 2019 May 18; 706:207-210. PMID: 31108129.
      View in: PubMed
    2. Witkiewitz K, Falk DE, Litten RZ, Hasin DS, Kranzler HR, Mann KF, O'Malley SS, Anton RF. Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2019 May; 43(5):979-987. PMID: 30951210.
      View in: PubMed
    3. Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. JAMA Psychiatry. 2019 Mar 13. PMID: 30865232.
      View in: PubMed
    4. Knox J, Scodes J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Anton R, Hasin DS. Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population. Drug Alcohol Depend. 2019 04 01; 197:228-235. PMID: 30852375.
      View in: PubMed
    5. Prisciandaro JJ, Schacht JP, Prescot AP, Renshaw PF, Brown TR, Anton RF. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers. Alcohol Clin Exp Res. 2019 Feb; 43(2):221-226. PMID: 30537347.
      View in: PubMed
    6. Witkiewitz K, Kranzler HR, Hallgren KA, O'Malley SS, Falk DE, Litten RZ, Hasin DS, Mann KF, Anton RF. Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder. Alcohol Clin Exp Res. 2018 Dec; 42(12):2453-2465. PMID: 30395350.
      View in: PubMed
    7. Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS. Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population. Alcohol Clin Exp Res. 2018 Nov; 42(11):2256-2265. PMID: 30204248.
      View in: PubMed
    8. Schacht JP, Anton RF, McNamara PJ, Im Y, King AC. The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addict Biol. 2018 Sep 18. PMID: 30230123.
      View in: PubMed
    9. Stewart SH, Reuben A, Anton RF. Reply: Carbohydrate Deficient Transferrin in Patients with Cirrhosis: A Tale of Bridges. Alcohol Alcohol. 2018 05 01; 53(3):351-352. PMID: 29462240.
      View in: PubMed
    10. Kearney-Ramos TE, Dowdle LT, Lench DH, Mithoefer OJ, Devries WH, George MS, Anton RF, Hanlon CA. Transdiagnostic Effects of Ventromedial Prefrontal Cortex Transcranial Magnetic Stimulation on Cue Reactivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 07; 3(7):599-609. PMID: 29776789.
      View in: PubMed
    11. Anton RF, Latham PK, Voronin KE, Randall PK, Book SW, Hoffman M, Schacht JP. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res. 2018 Apr; 42(4):751-760. PMID: 29431852.
      View in: PubMed
    12. Schacht JP, Voronin KE, Randall PK, Anton RF. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. Neuropsychopharmacology. 2018 05; 43(6):1247-1256. PMID: 29362512.
      View in: PubMed
    13. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 12; 42(13):2654. PMID: 29123234.
      View in: PubMed
    14. Matar MM, Jewett B, Fakhry SM, Wilson DA, Ferguson PL, Anton RF, Sakran JV. Identifying chronic heavy alcohol use in emergency general surgery patients: a pilot study. Trauma Surg Acute Care Open. 2017; 2(1):e000098. PMID: 29766097.
      View in: PubMed
    15. Prisciandaro JJ, Tolliver BK, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton RF. Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence. Transl Psychiatry. 2017 07 04; 7(7):e1163. PMID: 28675386.
      View in: PubMed
    16. Anton RF, Schacht JP, Voronin KE, Randall PK. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control. Alcohol Clin Exp Res. 2017 Jul; 41(7):1370-1380. PMID: 28493623.
      View in: PubMed
    17. Hanlon CA, Dowdle LT, Correia B, Mithoefer O, Kearney-Ramos T, Lench D, Griffin M, Anton RF, George MS. Left frontal pole theta burst stimulation decreases orbitofrontal and insula activity in cocaine users and alcohol users. Drug Alcohol Depend. 2017 09 01; 178:310-317. PMID: 28686990.
      View in: PubMed
    18. Litten RZ, Falk DE, O'Malley SS, Witkiewitz KA, Mann KF, Anton RF. Letter to Editor in Response to Johnson's Commentary (2017) on the Witkiewitz and Colleagues (2017) Article. Alcohol Clin Exp Res. 2017 07; 41(7):1381-1382. PMID: 28471501.
      View in: PubMed
    19. Hasin DS, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Robinson RL, Anton R. Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population. Lancet Psychiatry. 2017 06; 4(6):469-476. PMID: 28456501.
      View in: PubMed
    20. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 Dec; 42(13):2640-2653. PMID: 28409564.
      View in: PubMed
    21. Witkiewitz K, Wilson AD, Pearson MR, Hallgren KA, Falk DE, Litten RZ, Kranzler HR, Mann KF, Hasin DS, O'Malley SS, Anton RF. Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study. Alcohol Clin Exp Res. 2017 May; 41(5):1054-1062. PMID: 28295414.
      View in: PubMed
    22. Helander A, Wielders J, Anton R, Arndt T, Bianchi V, Deenmamode J, Jeppsson JO, Whitfield JB, Weykamp C, Schellenberg F. Reprint of Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clin Chim Acta. 2017 Apr; 467:15-20. PMID: 28322729.
      View in: PubMed
    23. Witkiewitz K, Hallgren KA, Kranzler HR, Mann KF, Hasin DS, Falk DE, Litten RZ, O'Malley SS, Anton RF. Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels. Alcohol Clin Exp Res. 2017 01; 41(1):179-186. PMID: 28019652.
      View in: PubMed
    24. Schellenberg F, Wielders J, Anton R, Bianchi V, Deenmamode J, Weykamp C, Whitfield J, Jeppsson JO, Helander A. IFCC approved HPLC reference measurement procedure for the alcohol consumption biomarker carbohydrate-deficient transferrin (CDT): Its validation and use. Clin Chim Acta. 2017 Feb; 465:91-100. PMID: 28025028.
      View in: PubMed
    25. Stewart SH, Reuben A, Anton RF. Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease. Alcohol Alcohol. 2017 Jan; 52(1):24-28. PMID: 27998920.
      View in: PubMed
    26. Hahn JA, Anton RF, Javors MA. The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice. Alcohol Clin Exp Res. 2016 11; 40(11):2292-2295. PMID: 27716960.
      View in: PubMed
    27. Post A, Smart TS, Jackson K, Mann J, Mohs R, Rorick-Kehn L, Statnick M, Anton R, O'Malley SS, Wong CJ. Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence. Alcohol Clin Exp Res. 2016 09; 40(9):1935-44. PMID: 27435979.
      View in: PubMed
    28. Hallgren KA, Witkiewitz K, Kranzler HR, Falk DE, Litten RZ, O'Malley SS, Anton RF. Missing Data in Alcohol Clinical Trials with Binary Outcomes. Alcohol Clin Exp Res. 2016 07; 40(7):1548-57. PMID: 27254113.
      View in: PubMed
    29. Helander A, Wielders J, Anton R, Arndt T, Bianchi V, Deenmamode J, Jeppsson JO, Whitfield JB, Weykamp C, Schellenberg F. Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clin Chim Acta. 2016 Aug 01; 459:19-24. PMID: 27221205.
      View in: PubMed
    30. Boyd SJ, Schacht JP, Prisciandaro JJ, Voronin K, Anton RF. Alcohol-Induced Stimulation Mediates the Effect of a GABRA2 SNP on Alcohol Self-Administrated among Alcohol-Dependent Individuals. Alcohol Alcohol. 2016 Sep; 51(5):549-54. PMID: 27117237.
      View in: PubMed
    31. McHugh RK, Fitzmaurice GM, Griffin ML, Anton RF, Weiss RD. Association between a brief alcohol craving measure and drinking in the following week. Addiction. 2016 06; 111(6):1004-10. PMID: 26780476.
      View in: PubMed
    32. Adams ZW, Schacht JP, Randall P, Anton RF. The Reasons for Heavy Drinking Questionnaire: Factor Structure and Validity in Alcohol-Dependent Adults Involved in Clinical Trials. J Stud Alcohol Drugs. 2016 Mar; 77(2):354-61. PMID: 26997195.
      View in: PubMed
    33. Prisciandaro JJ, Schacht JP, Prescot AP, Renshaw PF, Brown TR, Anton RF. Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence. Alcohol Clin Exp Res. 2016 Mar; 40(3):491-6. PMID: 26853538.
      View in: PubMed
    34. Tolliver BK, Anton RF. Assessment and treatment of mood disorders in the context of substance abuse. Dialogues Clin Neurosci. 2015 Jun; 17(2):181-90. PMID: 26246792.
      View in: PubMed
    35. Witkiewitz K, Falk DE, Kranzler HR, Litten RZ, Hallgren KA, O'Malley SS, Anton RF. Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials. Alcohol Clin Exp Res. 2014 Nov; 38(11):2826-34. PMID: 25421518.
      View in: PubMed
    36. Anton RF. Commentary on: ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res. 2014 Jul; 38(7):1826-8. PMID: 24961935.
      View in: PubMed
    37. Stewart SH, Koch DG, Willner IR, Anton RF, Reuben A. Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol Clin Exp Res. 2014 Jun; 38(6):1706-11. PMID: 24848614.
      View in: PubMed
    38. Weykamp C, Wielders J, Helander A, Anton RF, Bianchi V, Jeppsson JO, Siebelder C, Whitfield JB, Schellenberg F. Harmonization of measurement results of the alcohol biomarker carbohydrate-deficient transferrin by use of the toolbox of technical procedures of the International Consortium for Harmonization of Clinical Laboratory Results. Clin Chem. 2014 Jul; 60(7):945-53. PMID: 24691685.
      View in: PubMed
    39. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. Psychopharmacology (Berl). 2014 Sep; 231(18):3799-807. PMID: 24647921.
      View in: PubMed
    40. Greenfield TK, Ye Y, Bond J, Kerr WC, Nayak MB, Kaskutas LA, Anton RF, Litten RZ, Kranzler HR. Risks of alcohol use disorders related to drinking patterns in the U.S. general population. J Stud Alcohol Drugs. 2014 Mar; 75(2):319-27. PMID: 24650826.
      View in: PubMed
    41. Falk DE, Litten RZ, Anton RF, Kranzler HR, Johnson BA. Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials. J Stud Alcohol Drugs. 2014 Mar; 75(2):335-46. PMID: 24650828.
      View in: PubMed
    42. Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol. 2014 May-Jun; 49(3):261-70. PMID: 24421289.
      View in: PubMed
    43. Anton RF, Schacht JP, Book SW. Pharmacologic treatment of alcoholism. Handb Clin Neurol. 2014; 125:527-42. PMID: 25307594.
      View in: PubMed
    44. Gelernter J, Kranzler HR, Sherva R, Almasy L, Koesterer R, Smith AH, Anton R, Preuss UW, Ridinger M, Rujescu D, Wodarz N, Zill P, Zhao H, Farrer LA. Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci. Mol Psychiatry. 2014 Jan; 19(1):41-9. PMID: 24166409.
      View in: PubMed
    45. Anton RF. Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE Study. Addiction. 2013 Oct; 108(10):1745-6. PMID: 24033779.
      View in: PubMed
    46. Wong CJ, Witcher J, Mallinckrodt C, Dean RA, Anton RF, Chen Y, Fijal BA, Ouyang H, Dharia S, Sundseth SS, Schuh KJ, Kinon BJ. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence. Alcohol Clin Exp Res. 2014 Feb; 38(2):511-20. PMID: 24010675.
      View in: PubMed
    47. Weykamp C, Wielders JP, Helander A, Anton RF, Bianchi V, Jeppsson JO, Siebelder C, Whitfield JB, Schellenberg F. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible. Clin Chem Lab Med. 2013 May; 51(5):991-6. PMID: 23241602.
      View in: PubMed
    48. DeSantis SM, Bandyopadhyay D, Baker NL, Randall PK, Anton RF, Prisciandaro JJ. Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):244-50. PMID: 23566774.
      View in: PubMed
    49. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl). 2013 Jun; 227(4):627-37. PMID: 23389755.
      View in: PubMed
    50. Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol. 2013 Nov; 18(6):937-46. PMID: 23231446.
      View in: PubMed
    51. Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, Myrick H. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology. 2013 Feb; 38(3):414-22. PMID: 23032071.
      View in: PubMed
    52. Zhang H, Herman AI, Kranzler HR, Anton RF, Zhao H, Zheng W, Gelernter J. Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E108-15. PMID: 22924764.
      View in: PubMed
    53. Zhang H, Herman AI, Kranzler HR, Anton RF, Simen AA, Gelernter J. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. J Hum Genet. 2012 Oct; 57(10):670-5. PMID: 22914673.
      View in: PubMed
    54. Bakhireva LN, Cano S, Rayburn WF, Savich RD, Leeman L, Anton RF, Savage DD. Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women. Alcohol Alcohol. 2012 Nov-Dec; 47(6):683-7. PMID: 22878591.
      View in: PubMed
    55. Zhang H, Wang F, Kranzler HR, Anton RF, Gelernter J. Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. Behav Brain Funct. 2012 May 16; 8:23. PMID: 22591552.
      View in: PubMed
    56. Schacht JP, Anton RF, Myrick H. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol. 2013 Jan; 18(1):121-33. PMID: 22574861.
      View in: PubMed
    57. Anton RF, Voronin KK, Randall PK, Myrick H, Tiffany A. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. Alcohol Clin Exp Res. 2012 Nov; 36(11):2000-7. PMID: 22551036.
      View in: PubMed
    58. Han S, Yang BZ, Kranzler HR, Oslin D, Anton R, Farrer LA, Gelernter J. Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans. Biol Psychiatry. 2012 Oct 15; 72(8):637-44. PMID: 22520967.
      View in: PubMed
    59. Li D, Zhao H, Kranzler HR, Oslin D, Anton RF, Farrer LA, Gelernter J. Association of COL25A1 with comorbid antisocial personality disorder and substance dependence. Biol Psychiatry. 2012 Apr 15; 71(8):733-40. PMID: 22297151.
      View in: PubMed
    60. Chen J, Brunzell DH, Jackson K, van der Vaart A, Ma JZ, Payne TJ, Sherva R, Farrer LA, Gejman P, Levinson DF, Holmans P, Aggen SH, Damaj I, Kuo PH, Webb BT, Anton R, Kranzler HR, Gelernter J, Li MD, Kendler KS, Chen X. ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. PLoS One. 2011; 6(12):e28790. PMID: 22205969.
      View in: PubMed
    61. Xie P, Kranzler HR, Zhang H, Oslin D, Anton RF, Farrer LA, Gelernter J. Childhood adversity increases risk for nicotine dependence and interacts with a5 nicotinic acetylcholine receptor genotype specifically in males. Neuropsychopharmacology. 2012 Feb; 37(3):669-76. PMID: 22012472.
      View in: PubMed
    62. Kranzler HR, Feinn R, Nelson EC, Covault J, Anton RF, Farrer L, Gelernter J. A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women. Am J Med Genet B Neuropsychiatr Genet. 2011 Dec; 156B(8):960-8. PMID: 21998007.
      View in: PubMed
    63. Douglas K, Chan G, Gelernter J, Arias AJ, Anton RF, Poling J, Farrer L, Kranzler HR. 5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder. Psychiatr Genet. 2011 Oct; 21(5):240-8. PMID: 21399568.
      View in: PubMed
    64. Ittiwut C, Yang BZ, Kranzler HR, Anton RF, Hirunsatit R, Weiss RD, Covault J, Farrer LA, Gelernter J. GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcohol Clin Exp Res. 2012 Apr; 36(4):588-93. PMID: 21919924.
      View in: PubMed
    65. Chang SC, Xie P, Anton RF, De Vivo I, Farrer LA, Kranzler HR, Oslin D, Purcell SM, Roberts AL, Smoller JW, Uddin M, Gelernter J, Koenen KC. No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. Mol Psychiatry. 2012 Mar; 17(3):239-41. PMID: 21912390.
      View in: PubMed
    66. Anton RF, Litten RZ, Falk DE, Palumbo JM, Bartus RT, Robinson RL, Kranzler HR, Kosten TR, Meyer RE, O'Brien CP, Mann K, Meulien D. The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology. 2012 Jan; 37(2):402-11. PMID: 21900883.
      View in: PubMed
    67. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res. 2012 Mar; 36(3):385-94. PMID: 21895723.
      View in: PubMed
    68. Xie P, Kranzler HR, Krauthammer M, Cosgrove KP, Oslin D, Anton RF, Farrer LA, Picciotto MR, Krystal JH, Zhao H, Gelernter J. Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry. 2011 Sep 15; 70(6):528-36. PMID: 21683344.
      View in: PubMed
    69. Schacht JP, Randall PK, Waid LR, Baros AM, Latham PK, Wright TM, Myrick H, Anton RF. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011 Nov; 35(11):2030-8. PMID: 21631542.
      View in: PubMed
    70. Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul; 168(7):709-17. PMID: 21454917.
      View in: PubMed
    71. Han S, Yang BZ, Kranzler HR, Oslin D, Anton R, Gelernter J. Association of CHRNA4 polymorphisms with smoking behavior in two populations. Am J Med Genet B Neuropsychiatr Genet. 2011 Jun; 156B(4):421-9. PMID: 21445957.
      View in: PubMed
    72. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage. 2011 May 01; 56(1):61-8. PMID: 21316465.
      View in: PubMed
    73. Cui D, Zhang H, Yang BZ, Listman JB, Li D, Price LH, Carpenter LL, Tyrka AR, Anton RF, Kranzler HR, Gelernter J. Variation in NGFB is associated with primary affective disorders in women. Am J Med Genet B Neuropsychiatr Genet. 2011 Jun; 156B(4):401-12. PMID: 21294249.
      View in: PubMed
    74. Leventhal AM, Gelernter J, Oslin D, Anton RF, Farrer LA, Kranzler HR. Agitated depression in substance dependence. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):163-9. PMID: 21277711.
      View in: PubMed
    75. Herman AI, Conner TS, Anton RF, Gelernter J, Kranzler HR, Covault J. Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics. Addict Biol. 2011 Jan; 16(1):124-32. PMID: 20192950.
      View in: PubMed
    76. Stewart SH, Comte-Walters S, Bowen E, Anton RF. Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series. Alcohol Clin Exp Res. 2010 Nov; 34(11):1956-60. PMID: 20659069.
      View in: PubMed
    77. Helander A, Wielders JP, Jeppsson JO, Weykamp C, Siebelder C, Anton RF, Schellenberg F, Whitfield JB. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material. Clin Chem Lab Med. 2010 Nov; 48(11):1585-92. PMID: 21034250.
      View in: PubMed
    78. Myrick H, Li X, Randall PK, Henderson S, Voronin K, Anton RF. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol. 2010 Aug; 30(4):365-72. PMID: 20571434.
      View in: PubMed
    79. Sherva R, Kranzler HR, Yu Y, Logue MW, Poling J, Arias AJ, Anton RF, Oslin D, Farrer LA, Gelernter J. Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology. 2010 Aug; 35(9):1921-31. PMID: 20485328.
      View in: PubMed
    80. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Farrer LA, Gelernter J. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology. 2010 Jul; 35(8):1684-92. PMID: 20393453.
      View in: PubMed
    81. Anton RF. Editorial commentary: alcohol biomarker papers. Alcohol Clin Exp Res. 2010 Jun; 34(6):939-40. PMID: 20374210.
      View in: PubMed
    82. Vergne DE, Anton RF. Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets. 2010 Mar; 9(1):50-4. PMID: 20201815.
      View in: PubMed
    83. Anton R. Substance abuse is a disease of the human brain: focus on alcohol. J Law Med Ethics. 2010; 38(4):735-44. PMID: 21105937.
      View in: PubMed
    84. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, Weiss RD, Farrer L, Gelernter J. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry. 2009 Nov; 66(11):1201-9. PMID: 19884608.
      View in: PubMed
    85. Douglas KR, Chan G, Gelernter J, Arias AJ, Anton RF, Weiss RD, Brady K, Poling J, Farrer L, Kranzler HR. Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav. 2010 Jan; 35(1):7-13. PMID: 19720467.
      View in: PubMed
    86. Niciu MJ, Chan G, Gelernter J, Arias AJ, Douglas K, Weiss R, Anton RF, Farrer L, Cubells JF, Kranzler HR. Subtypes of major depression in substance dependence. Addiction. 2009 Oct; 104(10):1700-9. PMID: 19681804.
      View in: PubMed
    87. Anton RF, Myrick H, Baros AM, Latham PK, Randall PK, Wright TM, Stewart SH, Waid R, Malcolm R. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42. PMID: 19593171.
      View in: PubMed
    88. Miller PM, Cluver J, Anton RF. A useful test for monitoring alcohol use. Behav Healthc. 2009 Jun; 29(6):38, 40. PMID: 19655583.
      View in: PubMed
    89. Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8. PMID: 19485969.
      View in: PubMed
    90. Kranzler HR, Gelernter J, Anton RF, Arias AJ, Herman A, Zhao H, Burian L, Covault J. Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence. Alcohol Clin Exp Res. 2009 May; 33(5):925-30. PMID: 19320626.
      View in: PubMed
    91. Zuo L, Luo X, Listman JB, Kranzler HR, Wang S, Anton RF, Blumberg HP, Stein MB, Pearlson GD, Covault J, Charney DS, van Kammen DP, Price LH, Lappalainen J, Cramer J, Krystal JH, Gelernter J. Population admixture modulates risk for alcohol dependence. Hum Genet. 2009 Jun; 125(5-6):605-13. PMID: 19306106.
      View in: PubMed
    92. Farrer LA, Kranzler HR, Yu Y, Weiss RD, Brady KT, Anton R, Cubells JF, Gelernter J. Association of variants in MANEA with cocaine-related behaviors. Arch Gen Psychiatry. 2009 Mar; 66(3):267-74. PMID: 19255376.
      View in: PubMed
    93. LoCastro JS, Youngblood M, Cisler RA, Mattson ME, Zweben A, Anton RF, Donovan DM. Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study. J Stud Alcohol Drugs. 2009 Mar; 70(2):186-96. PMID: 19261230.
      View in: PubMed
    94. Zhang H, Kranzler HR, Weiss RD, Luo X, Brady KT, Anton RF, Farrer LA, Gelernter J. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry. 2009 Jul 15; 66(2):128-36. PMID: 19217079.
      View in: PubMed
    95. Oroszi G, Anton RF, O'Malley S, Swift R, Pettinati H, Couper D, Yuan Q, Goldman D. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res. 2009 Mar; 33(3):383-93. PMID: 19053977.
      View in: PubMed
    96. Stewart SH, Oroszi G, Randall PK, Anton RF. COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study. Am J Hypertens. 2009 Jan; 22(1):87-91. PMID: 19023276.
      View in: PubMed
    97. Stewart SH, Latham PK, Miller PM, Randall P, Anton RF. Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. Addiction. 2008 Oct; 103(10):1622-8. PMID: 18821872.
      View in: PubMed
    98. Luo X, Zuo L, Kranzler HR, Wang S, Anton RF, Gelernter J. Recessive genetic mode of an ADH4 variant in substance dependence in African-Americans: A model of utility of the HWD test. Behav Brain Funct. 2008 Sep 18; 4:42. PMID: 18801187.
      View in: PubMed
    99. Voronin K, Randall P, Myrick H, Anton R. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. Alcohol Clin Exp Res. 2008 Nov; 32(11):1954-61. PMID: 18782344.
      View in: PubMed
    100. Anton RF. Naltrexone for the management of alcohol dependence. N Engl J Med. 2008 Aug 14; 359(7):715-21. PMID: 18703474.
      View in: PubMed
    101. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med. 2008 Jun 09; 168(11):1188-99. PMID: 18541827.
      View in: PubMed
    102. Anton RF. Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence. Pharmacogenomics. 2008 Jun; 9(6):655-8. PMID: 18518841.
      View in: PubMed
    103. Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry. 2008 Apr; 65(4):466-75. PMID: 18391135.
      View in: PubMed
    104. Baros AM, Latham PK, Anton RF. Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist? Alcohol Clin Exp Res. 2008 May; 32(5):771-6. PMID: 18336635.
      View in: PubMed
    105. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry. 2008 Feb; 65(2):135-44. PMID: 18250251.
      View in: PubMed
    106. Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol. 2008 Feb; 28(1):5-12. PMID: 18204334.
      View in: PubMed
    107. Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. J Stud Alcohol Drugs. 2008 Jan; 69(1):5-13. PMID: 18080059.
      View in: PubMed
    108. Baros AM, Wright TM, Latham PK, Miller PM, Anton RF. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment. Alcohol Alcohol. 2008 Mar-Apr; 43(2):192-7. PMID: 18039674.
      View in: PubMed
    109. Bauer LO, Covault J, Harel O, Das S, Gelernter J, Anton R, Kranzler HR. Variation in GABRA2 predicts drinking behavior in project MATCH subjects. Alcohol Clin Exp Res. 2007 Nov; 31(11):1780-7. PMID: 17949392.
      View in: PubMed
    110. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007 Oct 10; 298(14):1641-51. PMID: 17925516.
      View in: PubMed
    111. Covault J, Gelernter J, Jensen K, Anton R, Kranzler HR. Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene. Neuropsychopharmacology. 2008 Mar; 33(4):837-48. PMID: 17507911.
      View in: PubMed
    112. Baros AM, Latham PK, Moak DH, Voronin K, Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res. 2007 Apr; 31(4):596-603. PMID: 17374038.
      View in: PubMed
    113. Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnovitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr; 164(4 Suppl):5-123. PMID: 17569411.
      View in: PubMed
    114. Cluver JS, Miller PM, Anton RF. Case studies of the utility of serum carbohydrate-deficient transferrin (%CDT) in the clinical management of alcoholics. J Addict Med. 2007 Mar; 1(1):44-7. PMID: 21768932.
      View in: PubMed
    115. Wright TM, Myrick H, Malcolm R, Randall P, Boyle E, Henderson S, Anton R. Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification. J Addict Med. 2007 Mar; 1(1):15-20. PMID: 21768927.
      View in: PubMed
    116. Myrick H, Anton R, Voronin K, Wang W, Henderson S. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res. 2007 Feb; 31(2):221-7. PMID: 17250613.
      View in: PubMed
    117. Jeppsson JO, Arndt T, Schellenberg F, Wielders JP, Anton RF, Whitfield JB, Helander A. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med. 2007; 45(4):558-62. PMID: 17439340.
      View in: PubMed
    118. Ndjakou Lenta B, Vonthron-Sénécheau C, Fongang Soh R, Tantangmo F, Ngouela S, Kaiser M, Tsamo E, Anton R, Weniger B. In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medicinal plants. J Ethnopharmacol. 2007 Apr 20; 111(1):8-12. PMID: 17141994.
      View in: PubMed
    119. Anton RF, Youngblood M. Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study. Alcohol Clin Exp Res. 2006 Nov; 30(11):1878-83. PMID: 17067352.
      View in: PubMed
    120. Pettinati HM, Anton RF, Willenbring ML. The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence. Psychiatry (Edgmont). 2006 Oct; 3(10):36-9. PMID: 20877545.
      View in: PubMed
    121. Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, Anton RF, Randall PK. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J Stud Alcohol. 2006 Sep; 67(5):700-6. PMID: 16847538.
      View in: PubMed
    122. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry. 2006 Aug; 163(8 Suppl):5-82. PMID: 16981488.
      View in: PubMed
    123. Brady KT, Back SE, Waldrop AE, McRae AL, Anton RF, Upadhyaya HP, Saladin ME, Randall PK. Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol Clin Exp Res. 2006 Jun; 30(6):938-46. PMID: 16737451.
      View in: PubMed
    124. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006 May 03; 295(17):2003-17. PMID: 16670409.
      View in: PubMed
    125. Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF, Dillie KS. Alcohol biomarker screening in medical and surgical settings. Alcohol Clin Exp Res. 2006 Feb; 30(2):185-93. PMID: 16441267.
      View in: PubMed
    126. Deas D, May MP, Randall C, Johnson N, Anton R. Naltrexone treatment of adolescent alcoholics: an open-label pilot study. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):723-8. PMID: 16262589.
      View in: PubMed
    127. Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, Thevos A, Wang W, Woolson R. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005 Aug; 25(4):349-57. PMID: 16012278.
      View in: PubMed
    128. Goldman D, Oroszi G, O'Malley S, Anton R. COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms. J Stud Alcohol Suppl. 2005 Jul; (15):56-64; discussion 33. PMID: 16223057.
      View in: PubMed
    129. Anton RE, Randall CL. Measurement and choice of drinking outcome variables in the COMBINE Study. J Stud Alcohol Suppl. 2005 Jul; (15):104-9; discussion 92-3. PMID: 16223062.
      View in: PubMed
    130. Alling C, Chick JD, Anton R, Mayfield RD, Salaspuro M, Helander A, Harris RA. Revealing alcohol abuse: to ask or to test? Alcohol Clin Exp Res. 2005 Jul; 29(7):1257-63. PMID: 16088981.
      View in: PubMed
    131. Hosking JD, Cisler RA, Couper DJ, Gastfriend DR, Kivlahan DR, Anton RF. Design and analysis of trials of combination therapies. J Stud Alcohol Suppl. 2005 Jul; (15):34-42; discussion 33. PMID: 16223054.
      View in: PubMed
    132. Weniger B, Vonthron-Sénécheau C, Kaiser M, Brun R, Anton R. Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids. Phytomedicine. 2006 Feb; 13(3):176-80. PMID: 16428025.
      View in: PubMed
    133. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51. PMID: 16088298.
      View in: PubMed
    134. Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar; 29(3):395-401. PMID: 15770115.
      View in: PubMed
    135. Weniger B, Vonthron-Sénécheau C, Arango GJ, Kaiser M, Brun R, Anton R. A bioactive biflavonoid from Campnosperma panamense. Fitoterapia. 2004 Dec; 75(7-8):764-7. PMID: 15567260.
      View in: PubMed
    136. Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res. 2004 Nov; 28(11):1710-7. PMID: 15547458.
      View in: PubMed
    137. Myrick H, Anton R. Recent advances in the pharmacotherapy of alcoholism. Curr Psychiatry Rep. 2004 Oct; 6(5):332-8. PMID: 15355755.
      View in: PubMed
    138. Miller PM, Anton RF. Biochemical alcohol screening in primary health care. Addict Behav. 2004 Sep; 29(7):1427-37. PMID: 15345274.
      View in: PubMed
    139. Drobes DJ, Anton RF, Thomas SE, Voronin K. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcohol Clin Exp Res. 2004 Sep; 28(9):1362-70. PMID: 15365307.
      View in: PubMed
    140. Fleming MF, Anton RF, Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res. 2004 Sep; 28(9):1347-55. PMID: 15365305.
      View in: PubMed
    141. Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol. 2004 Aug; 24(4):421-8. PMID: 15232334.
      View in: PubMed
    142. Littleton JM, De Witte P, Litten R, Gessa GL, Spanagel R, Kranzler H, Lehert P, Johnson B, Saunders J, Berglund M, Harris A, Anton R, Mann K. Challenges to medications development in treating alcohol dependence: an international perspective. Alcohol Alcohol. 2004 Jul-Aug; 39(4):271-5. PMID: 15208155.
      View in: PubMed
    143. Labbate LA, Sonne SC, Randal CL, Anton RF, Brady KT. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders? Compr Psychiatry. 2004 Jul-Aug; 45(4):304-10. PMID: 15224273.
      View in: PubMed
    144. Miller PM, Ornstein SM, Nietert PJ, Anton RF. Self-report and biomarker alcohol screening by primary care physicians: the need to translate research into guidelines and practice. Alcohol Alcohol. 2004 Jul-Aug; 39(4):325-8. PMID: 15208165.
      View in: PubMed
    145. Thomas SE, Drobes DJ, Voronin K, Anton RF. Following alcohol consumption, nontreatment-seeking alcoholics report greater stimulation but similar sedation compared with social drinkers. J Stud Alcohol. 2004 May; 65(3):330-5. PMID: 15222589.
      View in: PubMed
    146. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology. 2004 Feb; 29(2):393-402. PMID: 14679386.
      View in: PubMed
    147. Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl). 2004 Apr; 173(1-2):32-40. PMID: 14722705.
      View in: PubMed
    148. Schilter B, Andersson C, Anton R, Constable A, Kleiner J, O'Brien J, Renwick AG, Korver O, Smit F, Walker R. Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem Toxicol. 2003 Dec; 41(12):1625-49. PMID: 14563389.
      View in: PubMed
    149. Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol. 2003 Dec; 23(6):553-62. PMID: 14624185.
      View in: PubMed
    150. Nellissery M, Feinn RS, Covault J, Gelernter J, Anton RF, Pettinati H, Moak D, Mueller T, Kranzler HR. Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics. Alcohol Clin Exp Res. 2003 Sep; 27(9):1402-8. PMID: 14506400.
      View in: PubMed
    151. Gastfriend DR, Rubin A, Sharon E, Turner WM, Anton RF, Donovan DM, Gorski T, Marlatt GA, Maisto S, Schultz TK, Shulman GD. New constructs and assessments for relapse and continued use potential in the ASAM Patient Placement Criteria. J Addict Dis. 2003; 22 Suppl 1:95-111. PMID: 15991592.
      View in: PubMed
    152. Allen JP, Anton R. Biomarkers as aids to identification of relapse in alcoholic patients. Recent Dev Alcohol. 2003; 16:25-38. PMID: 12638630.
      View in: PubMed
    153. Anton RF, Swift RM. Current pharmacotherapies of alcoholism: a U.S. perspective. Am J Addict. 2003; 12(s1):s53-s68. PMID: 14972780.
      View in: PubMed
    154. Drobes DJ, Anton RF, Thomas SE, Voronin K. A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene. Neuropsychopharmacology. 2003 Apr; 28(4):755-64. PMID: 12655322.
      View in: PubMed
    155. Rukstalis MR, Lynch KG, Oslin DW, Pettinati HM, Anderson SM, Volpicelli JR, Anton RF. Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment. Alcohol Clin Exp Res. 2002 Oct; 26(10):1539-44. PMID: 12394287.
      View in: PubMed
    156. Deas D, Roberts JS, Randall CL, Anton RF. Confirmatory analysis of the adolescent obsessive compulsive drinking scale (A-OCDS): a measure of 'craving' and problem drinking in adolescents/young adults. J Natl Med Assoc. 2002 Oct; 94(10):879-87. PMID: 12408692.
      View in: PubMed
    157. Shively CA, Williams JK, Laber-Laird K, Anton RF. Depression and coronary artery atherosclerosis and reactivity in female cynomolgus monkeys. Psychosom Med. 2002 Sep-Oct; 64(5):699-706. PMID: 12271100.
      View in: PubMed
    158. Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res. 2002 Aug; 26(8):1215-22. PMID: 12198396.
      View in: PubMed
    159. Lobstein A, Yepes Y, Um BH, Weniger B, Lugnier C, Anton R. Bioactive compounds from Leycesteria formosa. Pharmazie. 2002 Jun; 57(6):431-2. PMID: 12116886.
      View in: PubMed
    160. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002 May; 17(5):349-55. PMID: 12047731.
      View in: PubMed
    161. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict. 2002; 11(2):141-50. PMID: 12028744.
      View in: PubMed
    162. DiMartini A, Day N, Lane T, Beisler AT, Dew MA, Anton R. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res. 2001 Dec; 25(12):1729-33. PMID: 11781505.
      View in: PubMed
    163. Anton RF. Naltrexone for alcohol dependence: comments on Morris et al. (2001). Addiction. 2001 Dec; 96(12):1855. PMID: 11784478.
      View in: PubMed
    164. Weniger B, Robledo S, Arango GJ, Deharo E, Aragón R, Muñoz V, Callapa J, Lobstein A, Anton R. Antiprotozoal activities of Colombian plants. J Ethnopharmacol. 2001 Dec; 78(2-3):193-200. PMID: 11694364.
      View in: PubMed
    165. Um BH, Weniger B, Lobstein A, Pouplin T, Polat M, Aragón R, Anton R. Triterpenoid saponins from Isertia pittieri. J Nat Prod. 2001 Dec; 64(12):1588-9. PMID: 11754623.
      View in: PubMed
    166. Anton RF. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol. 2001 Nov; 25(3):185-8. PMID: 11839464.
      View in: PubMed
    167. Anton RF, Dominick C, Bigelow M, Westby C. Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase. Clin Chem. 2001 Oct; 47(10):1769-75. PMID: 11568085.
      View in: PubMed
    168. Weniger B, Um BH, Valentin A, Estrada A, Lobstein A, Anton R, Maillé M, Sauvain M. Bioactive acridone alkaloids from Swinglea glutinosa. J Nat Prod. 2001 Sep; 64(9):1221-3. PMID: 11575960.
      View in: PubMed
    169. Myrick H, Henderson S, Anton RF. Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study. Alcohol Clin Exp Res. 2001 Sep; 25(9):1330-4. PMID: 11584153.
      View in: PubMed
    170. Johnson DE, Epstein JN, Waid LR, Latham PK, Voronin KE, Anton RF. Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder. Arch Clin Neuropsychol. 2001 Aug; 16(6):587-604. PMID: 14590156.
      View in: PubMed
    171. Um BH, Pouplin T, Lobstein A, Weniger B, Litaudon M, Anton R. Saponins from Strasburgeria robusta. Fitoterapia. 2001 Jun; 72(5):591-3. PMID: 11429265.
      View in: PubMed
    172. Lakshman R, Tsutsumi M, Ghosh P, Takase S, Anni H, Nikolaeva O, Israel Y, Anton RF, Lesch OM, Helender A, Eriksson G, Jeppson JO, Marmillot P, Rao MN. Alcohol biomarkers: clinical significance and biochemical basis. Alcohol Clin Exp Res. 2001 May; 25(5 Suppl ISBRA):67S-70S. PMID: 11391052.
      View in: PubMed
    173. Mann K, Agartz I, Harper C, Shoaf S, Rawlings RR, Momenan R, Hommer DW, Pfefferbaum A, Sullivan EV, Anton RF, Drobes DJ, George MS, Bares R, Machulla HJ, Mundle G, Reimold M, Heinz A. Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res. 2001 May; 25(5 Suppl ISBRA):104S-109S. PMID: 11391058.
      View in: PubMed
    174. Lobstein A, Brenne X, Feist E, Metz N, Weniger B, Anton R. Quantitative determination of naphthoquinones of Impatiens species. Phytochem Anal. 2001 May-Jun; 12(3):202-5. PMID: 11705027.
      View in: PubMed
    175. George MS, Anton RF, Bloomer C, Teneback C, Drobes DJ, Lorberbaum JP, Nahas Z, Vincent DJ. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry. 2001 Apr; 58(4):345-52. PMID: 11296095.
      View in: PubMed
    176. Deas D, Roberts J, Randall C, Anton R. Adolescent Obsessive-Compulsive Drinking Scale: an assessment tool for problem drinking. J Natl Med Assoc. 2001 Mar; 93(3):92-103. PMID: 12656441.
      View in: PubMed
    177. Flannery BA, Roberts AJ, Cooney N, Swift RM, Anton RF, Rohsenow DJ. The role of craving in alcohol use, dependence, and treatment. Alcohol Clin Exp Res. 2001 Feb; 25(2):299-308. PMID: 11236847.
      View in: PubMed
    178. Anton RF, Moak DH, Latham PK, Waid LR, Malcolm RJ, Dias JK, Roberts JS. Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. J Clin Psychopharmacol. 2001 Feb; 21(1):72-7. PMID: 11199951.
      View in: PubMed
    179. Anton RF. Pharmacologic approaches to the management of alcoholism. J Clin Psychiatry. 2001; 62 Suppl 20:11-7. PMID: 11584870.
      View in: PubMed
    180. Brouette T, Anton R. Clinical review of inhalants. Am J Addict. 2001; 10(1):79-94. PMID: 11268830.
      View in: PubMed
    181. Weniger B, Aragon R, Deharo E, Bastida J, Codina C, Lobstein A, Anton R. Antimalarial constituents from Guatteria amplifolia. Pharmazie. 2000 Nov; 55(11):867-8. PMID: 11126013.
      View in: PubMed
    182. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol. 2000 Nov-Dec; 35(6):587-93. PMID: 11093966.
      View in: PubMed
    183. Malcolm R, Roberts JS, Wang W, Myrick H, Anton RF. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000 Nov; 22(3):159-64. PMID: 11163123.
      View in: PubMed
    184. Anton RF. Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale. Addiction. 2000 Aug; 95 Suppl 2:S211-7. PMID: 11002915.
      View in: PubMed
    185. Malcolm R, Kajdasz DK, Herron J, Anton RF, Brady KT. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000 Aug 01; 60(2):161-8. PMID: 10940543.
      View in: PubMed
    186. Deas D, Randall CL, Roberts JS, Anton RF. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Hum Psychopharmacol. 2000 Aug; 15(6):461-469. PMID: 12404308.
      View in: PubMed
    187. Frantz M, Jung ML, Ribereau-Gayon G, Anton R. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins. Arzneimittelforschung. 2000 May; 50(5):471-8. PMID: 10858875.
      View in: PubMed
    188. Drobes DJ, Anton RF. Drinking in alcoholics following an alcohol challenge research protocol. J Stud Alcohol. 2000 Mar; 61(2):220-4. PMID: 10757131.
      View in: PubMed
    189. Malcolm R, Herron JE, Anton RF, Roberts J, Moore J. Recurrent detoxification may elevate alcohol craving as measured by the Obsessive Compulsive Drinking scale. Alcohol. 2000 Feb; 20(2):181-5. PMID: 10719797.
      View in: PubMed
    190. Myrick H, Anton RF. Clinical management of alcohol withdrawal. CNS Spectr. 2000 Feb; 5(2):22-32. PMID: 18296996.
      View in: PubMed
    191. Babor TF, Steinberg K, Anton R, Del Boca F. Talk is cheap: measuring drinking outcomes in clinical trials. J Stud Alcohol. 2000 Jan; 61(1):55-63. PMID: 10627097.
      View in: PubMed
    192. Metz N, Lobstein A, Schneider Y, Gossé F, Schleiffer R, Anton R, Raul F. Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr Cancer. 2000; 38(1):60-4. PMID: 11341046.
      View in: PubMed
    193. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry. 1999 Nov; 156(11):1758-64. PMID: 10553740.
      View in: PubMed
    194. Roberts JS, Anton RF, Latham PK, Moak DH. Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcohol Clin Exp Res. 1999 Sep; 23(9):1484-91. PMID: 10512314.
      View in: PubMed
    195. Anton RF. Alcohol craving--a renaissance. Alcohol Clin Exp Res. 1999 Aug; 23(8):1287-8. PMID: 10470969.
      View in: PubMed
    196. George MS, Tenebäck CC, Malcolm RJ, Moore J, Stallings LE, Spicer KM, Anton RF, Ballenger JC. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period. Alcohol Clin Exp Res. 1999 Jun; 23(6):1077-84. PMID: 10397294.
      View in: PubMed
    197. Horner MD, Waid LR, Johnson DE, Latham PK, Anton RF. The relationship of cognitive functioning to amount of recent and lifetime alcohol consumption in outpatient alcoholics. Addict Behav. 1999 May-Jun; 24(3):449-53. PMID: 10400285.
      View in: PubMed
    198. Lenne-Gouverneur AF, Lobstein A, Haan-Archipoff G, Duportail G, Anton R, Kuhry JG. Interactions of the monomeric and dimeric flavones apigenin and amentoflavone with the plasma membrane of L929 cells; a fluorescence study. Mol Membr Biol. 1999 Apr-Jun; 16(2):157-65. PMID: 10417980.
      View in: PubMed
    199. Malcolm R, Anton RF, Conrad SE, Sutherland S. Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Alcohol. 1999 Jan; 17(1):7-11. PMID: 9895031.
      View in: PubMed
    200. Allen JP, Sillamaukee P, Anton R. Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism. Alcohol Clin Exp Res. 1999 Jan; 23(1):115-20. PMID: 10029211.
      View in: PubMed
    201. Anton RF. What is craving? Models and implications for treatment. Alcohol Res Health. 1999; 23(3):165-73. PMID: 10890811.
      View in: PubMed
    202. Andriambeloson E, Magnier C, Haan-Archipoff G, Lobstein A, Anton R, Beretz A, Stoclet JC, Andriantsitohaina R. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr. 1998 Dec; 128(12):2324-33. PMID: 9868177.
      View in: PubMed
    203. Anton RF, Stout RL, Roberts JS, Allen JP. The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics. Alcohol Clin Exp Res. 1998 Oct; 22(7):1456-62. PMID: 9802528.
      View in: PubMed
    204. Yeastedt J, La Grange L, Anton RF. Female alcoholic outpatients and female college students: a correlational study of self-reported alcohol consumption and carbohydrate-deficient transferrin levels. J Stud Alcohol. 1998 Sep; 59(5):555-9. PMID: 9718108.
      View in: PubMed
    205. Myrick H, Anton RF. Treatment of alcohol withdrawal. Alcohol Health Res World. 1998; 22(1):38-43. PMID: 15706731.
      View in: PubMed
    206. Moak DH, Anton RF, Latham PK. Further validation of the Obsessive-Compulsive Drinking Scale (OCDS). Relationship to alcoholism severity. Am J Addict. 1998; 7(1):14-23. PMID: 9522003.
      View in: PubMed
    207. Johnson DE, Waid LR, Anton RF. Childhood hyperactivity, gender, and Cloninger's personality dimensions in alcoholics. Addict Behav. 1997 Sep-Oct; 22(5):649-53. PMID: 9347067.
      View in: PubMed
    208. Anton RF, Kranzler HR, McEvoy JP, Moak DH, Bianca R. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Psychopharmacology (Berl). 1997 May; 131(2):123-9. PMID: 9201799.
      View in: PubMed
    209. Shively CA, Laber-Laird K, Anton RF. Behavior and physiology of social stress and depression in female cynomolgus monkeys. Biol Psychiatry. 1997 Apr 15; 41(8):871-82. PMID: 9099414.
      View in: PubMed
    210. Allen JP, Fertig JB, Litten RZ, Sillanaukee P, Anton RF. Proposed recommendations for research on biochemical markers for problematic drinking. Alcohol Clin Exp Res. 1997 Apr; 21(2):244-7. PMID: 9113259.
      View in: PubMed
    211. Ribéreau-Gayon G, Jung ML, Frantz M, Anton R. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs. 1997 Apr; 8 Suppl 1:S3-8. PMID: 9179359.
      View in: PubMed
    212. Ribéreau-Gayon G, Dumont S, Muller C, Jung ML, Poindron P, Anton R. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett. 1996 Dec 03; 109(1-2):33-8. PMID: 9020900.
      View in: PubMed
    213. Johnson BA, Jasinski DR, Galloway GP, Kranzler H, Weinreib R, Anton RF, Mason BJ, Bohn MJ, Pettinati HM, Rawson R, Clyde C. Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group. Psychopharmacology (Berl). 1996 Nov; 128(2):206-15. PMID: 8956382.
      View in: PubMed
    214. Anton RF. The use of carbohydrate deficient transferrin as an indicator of alcohol consumption during treatment and follow-up. Alcohol Clin Exp Res. 1996 Nov; 20(8 Suppl):54A-56A. PMID: 8947235.
      View in: PubMed
    215. Anton RF. Pharmacotherapy of alcoholism--10 years of progress. Alcohol Clin Exp Res. 1996 Nov; 20(8 Suppl):172A-175A. PMID: 8947259.
      View in: PubMed
    216. Anton RF. New methodologies for pharmacological treatment trials for alcohol dependence. Alcohol Clin Exp Res. 1996 Oct; 20(7 Suppl):3A-9A. PMID: 8904988.
      View in: PubMed
    217. Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB, Bissette G. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology. 1996 Sep; 15(3):288-95. PMID: 8873112.
      View in: PubMed
    218. Anton RF, Moak DH, Latham P. Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcohol Clin Exp Res. 1996 Aug; 20(5):841-6. PMID: 8865958.
      View in: PubMed
    219. Anton RF. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions. Alcohol Alcohol. 1996 Mar; 31 Suppl 1:43-53. PMID: 8737000.
      View in: PubMed
    220. Moak DH, Anton RF. Alcohol-related seizures and the kindling effect of repeated detoxifications: the influence of cocaine. Alcohol Alcohol. 1996 Mar; 31(2):135-43. PMID: 8737008.
      View in: PubMed
    221. Anton RF. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions. Alcohol Alcohol Suppl. 1996 Mar; 31(1):43-53. PMID: 9845037.
      View in: PubMed
    222. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996 Mar; 53(3):225-31. PMID: 8611059.
      View in: PubMed
    223. Oulad-Ali A, Kirchner V, Lobstein A, Weniger B, Anton R, Guillaume D, Charrouf Z. Structure elucidation of three triterpene glycosides from the trunk of Argania spinosa. J Nat Prod. 1996 Feb; 59(2):193-5. PMID: 8991953.
      View in: PubMed
    224. Weniger B, Rafik W, Bastida J, Quirion JC, Anton R. Indole alkaloids from Antirhea lucida. Planta Med. 1995 Dec; 61(6):569-70. PMID: 17238112.
      View in: PubMed
    225. Englert J, Weniger B, Lobstein A, Anton R, Krempp E, Guillaume D, Leroy Y. Triterpenoid saponins from Mimosa pigra. J Nat Prod. 1995 Aug; 58(8):1265-9. PMID: 7595593.
      View in: PubMed
    226. Bean P, Sutphin MS, Liu Y, Anton R, Reynolds TB, Shoenfeld Y, Peter JB. Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. Clin Chem. 1995 Jun; 41(6 Pt 1):858-61. PMID: 7768004.
      View in: PubMed
    227. Brady KT, Sonne SC, Anton R, Ballenger JC. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995 Mar; 56(3):118-21. PMID: 7883730.
      View in: PubMed
    228. Kane DJ, Ord T, Anton R, Bredesen DE. Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res. 1995 Feb 01; 40(2):269-75. PMID: 7745620.
      View in: PubMed
    229. La Grange L, Anton RF, Garcia S, Herrbold C. Carbohydrate-deficient transferrin levels in a female population. Alcohol Clin Exp Res. 1995 Feb; 19(1):100-3. PMID: 7771634.
      View in: PubMed
    230. Weniger B, Italiano L, Beck JP, Bastida J, Bergoñon S, Codina C, Lobstein A, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids. Planta Med. 1995 Feb; 61(1):77-9. PMID: 7701000.
      View in: PubMed
    231. Anton RF, Moak DH, Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res. 1995 Feb; 19(1):92-9. PMID: 7771669.
      View in: PubMed
    232. Anton RF, Kranzler HR, Meyer RE. Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. Clin Neurosci. 1995; 3(3):145-54. PMID: 8612059.
      View in: PubMed
    233. Nicolas G, Oulad-Ali A, Guillaume D, Lobstein A, Weniger B, Anton R. Triterpenoid saponins from the root of Sideroxylon foetidissimum. Phytochemistry. 1995 Jan; 38(1):225-8. PMID: 7766055.
      View in: PubMed
    234. Fuller RK, Mattson ME, Allen JP, Randall CL, Anton RF, Babor TF. Multisite clinical trials in alcoholism treatment research: organizational, methodological and management issues. J Stud Alcohol Suppl. 1994 Dec; 12:30-7. PMID: 7722995.
      View in: PubMed
    235. Connors GJ, Allen JP, Cooney NL, DiClemente CC, Tonigan JS, Anton RF. Assessment issues and strategies in alcoholism treatment matching research. J Stud Alcohol Suppl. 1994 Dec; 12:92-100. PMID: 7723004.
      View in: PubMed
    236. Babor TF, Longabaugh R, Zweben A, Fuller RK, Stout RL, Anton RF, Randall CL. Issues in the definition and measurement of drinking outcomes in alcoholism treatment research. J Stud Alcohol Suppl. 1994 Dec; 12:101-11. PMID: 7722986.
      View in: PubMed
    237. Kranzler HR, Anton RF. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. J Consult Clin Psychol. 1994 Dec; 62(6):1116-26. PMID: 7860810.
      View in: PubMed
    238. Burch EA, Anton RF, Carson WH. Mood congruent and incongruent psychotic depressions: are they the same? J Affect Disord. 1994 Aug; 31(4):275-80. PMID: 7989642.
      View in: PubMed
    239. Allen JP, Litten RZ, Anton RF, Cross GM. Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res. 1994 Aug; 18(4):799-812. PMID: 7978088.
      View in: PubMed
    240. La Grange L, Anton RF, Crow H, Garcia S. A correlational study of carbohydrate-deficient transferrin values and alcohol consumption among Hispanic college students. Alcohol Clin Exp Res. 1994 Jun; 18(3):653-6. PMID: 7943671.
      View in: PubMed
    241. Jiang Y, Weniger B, Quirion JC, Muller C, Anton R. 3alpha,5alpha-Tetrahydrodeoxycordifoline from Guettarda ovalifolia. Planta Med. 1994 Jun; 60(3):294. PMID: 17236053.
      View in: PubMed
    242. Anton RF, Moak DH. Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res. 1994 Jun; 18(3):747-54. PMID: 7943686.
      View in: PubMed
    243. Oulad-Ali A, Guillaume D, Weniger B, Jiang Y, Anton R. Mabiosides C-E: triterpenoid saponins from the bark of Colubrina elliptica. Phytochemistry. 1994 May; 36(2):445-8. PMID: 7764881.
      View in: PubMed
    244. Englert J, Jiang Y, Cabalion P, Oulad-Ali A, Anton R. C-Glycosoylflavones from Aerial Parts of Mimosa pudica. Planta Med. 1994 Apr; 60(2):194. PMID: 17236039.
      View in: PubMed
    245. Jiang Y, Ali AO, Guillaume D, Weniger B, Anton R. Triterpenoid saponins from the root of Sideroxylon cubense. Phytochemistry. 1994 Mar; 35(4):1013-5. PMID: 7764627.
      View in: PubMed
    246. Anton R, Bean P. Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared. Clin Chem. 1994 Mar; 40(3):364-8. PMID: 8131268.
      View in: PubMed
    247. Lydiard RB, Anton RF, Cunningham T. Interactions between sertraline and tricyclic antidepressants. Am J Psychiatry. 1993 Jul; 150(7):1125-6. PMID: 8317590.
      View in: PubMed
    248. Anton RF, Burch EA. Response of psychotic depression subtypes to pharmacotherapy. J Affect Disord. 1993 Jun; 28(2):125-31. PMID: 8354768.
      View in: PubMed
    249. Anton R, Jiang Y, Weniger B, Beck JP, Rivier L. Pharmacognosy of Mimosa tenuiflora (Willd.) Poiret. J Ethnopharmacol. 1993 Mar; 38(2-3):153-7. PMID: 8510463.
      View in: PubMed
    250. Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res. 1992 Dec; 16(6):1007-13. PMID: 1335217.
      View in: PubMed
    251. Dietrich JB, Ribéreau-Gayon G, Jung ML, Franz H, Beck JP, Anton R. Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins. Anticancer Drugs. 1992 Oct; 3(5):507-11. PMID: 1450445.
      View in: PubMed
    252. Randall CL, Anton RF, Becker HC, Hale RL, Ekblad U. Aspirin dose-dependently reduces alcohol-induced birth defects and prostaglandin E levels in mice. Teratology. 1991 Nov; 44(5):521-9. PMID: 1771594.
      View in: PubMed
    253. Lobstein A, Rietsch-Jako L, Haag-Berrurier M, Anton R. Seasonal Variations of the Flavonoid Content from Ginkgo biloba Leaves. Planta Med. 1991 Oct; 57(5):430-3. PMID: 17226181.
      View in: PubMed
    254. Abd el Hafiz MA, Ramadan MA, Jung ML, Beck JP, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids from Crinum augustum and Crinum bulbispermum. Planta Med. 1991 Oct; 57(5):437-9. PMID: 1798796.
      View in: PubMed
    255. Randall CL, Becker HC, Anton RF. Effect of ibuprofen on alcohol-induced teratogenesis in mice. Alcohol Clin Exp Res. 1991 Aug; 15(4):673-7. PMID: 1928642.
      View in: PubMed
    256. Johnston AL, Thevos AK, Randall CL, Anton RF. Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis. Br J Addict. 1991 Jun; 86(6):719-25. PMID: 1878622.
      View in: PubMed
    257. Adjibadé Y, Hue B, Pelhate M, Anton R. Action of calycanthine on nervous transmission in cockroach central nervous system. Planta Med. 1991 Apr; 57(2):99-101. PMID: 1653964.
      View in: PubMed
    258. Jiang YL, Massiot G, Lavaud C, Teulon JM, Guéchot C, Haag-Berrurier M, Anton R. Triterpenoid glycosides from the bark of Mimosa tenuiflora. Phytochemistry. 1991; 30(7):2357-60. PMID: 1367651.
      View in: PubMed
    259. Kellner CH, Grice DE, Pickrel SG, Anton RF, Joffe RT. Normalization of Augmented TRH Stimulation Test in Response to ECT. Convuls Ther. 1991; 7(2):125-128. PMID: 11941112.
      View in: PubMed
    260. Randall CL, Ekblad U, Anton RF. Perspectives on the pathophysiology of fetal alcohol syndrome. Alcohol Clin Exp Res. 1990 Dec; 14(6):807-12. PMID: 2088115.
      View in: PubMed
    261. Brady K, Anton R, Ballenger JC, Lydiard RB, Adinoff B, Selander J. Cocaine abuse among schizophrenic patients. Am J Psychiatry. 1990 Sep; 147(9):1164-7. PMID: 2386250.
      View in: PubMed
    262. Becker HC, Anton RF. Valproate potentiates and picrotoxin antagonizes the anxiolytic action of ethanol in a nonshock conflict task. Neuropharmacology. 1990 Sep; 29(9):837-43. PMID: 1981382.
      View in: PubMed
    263. Anton RF, Burch EA. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry. 1990 Sep; 147(9):1203-8. PMID: 2201223.
      View in: PubMed
    264. Anton R, Beretz A. [Flavonoids: antithrombotic agents or nutrients?]. Bull Acad Natl Med. 1990 Jun-Jul; 174(6):709-14; discussion 714-7. PMID: 2271980.
      View in: PubMed
    265. Adjibadé Y, Saad H, Kuballa B, Beck JP, Sévenet T, Cabalion P, Anton R. In vitro cytotoxicity of polyindolenine alkaloids on rat hepatoma cell lines. Structure activity relationships. J Ethnopharmacol. 1990 May; 29(2):127-36. PMID: 2374427.
      View in: PubMed
    266. Adjibadé Y, Saad H, Sévenet T, Kuballa B, Quirion JC, Anton R. New Polyindolenine Alkaloids from Calycodendron milnei. Planta Med. 1990 Apr; 56(2):212-5. PMID: 17221397.
      View in: PubMed
    267. Keochanthala-Bounthanh C, Haag-Berrurier M, Beck JP, Anton R. Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. Planta Med. 1990 Apr; 56(2):190-2. PMID: 2353067.
      View in: PubMed
    268. Willenbring ML, Anton RF, Spring WD, Shafer RB, Dorus W. Thyrotropin and prolactin response to thyrotropin-releasing hormone in depressed and nondepressed alcoholic men. Biol Psychiatry. 1990 Jan 01; 27(1):31-8. PMID: 2105105.
      View in: PubMed
    269. Anton RF, Becker HC, Randall CL. Ethanol increases PGE and thromboxane production in mouse pregnant uterine tissue. Life Sci. 1990; 46(16):1145-53. PMID: 2342401.
      View in: PubMed
    270. Adjibadé Y, Kuballa B, Cabalion P, Jung ML, Beck JP, Anton R. Cytotoxicity on human leukemic and rat hepatoma cell lines of alkaloid extracts of Psychotria forsteriana. Planta Med. 1989 Dec; 55(6):567-8. PMID: 2616674.
      View in: PubMed
    271. Dorus W, Ostrow DG, Anton R, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malkerneker U, et al. Lithium treatment of depressed and nondepressed alcoholics. JAMA. 1989 Sep 22-29; 262(12):1646-52. PMID: 2504944.
      View in: PubMed
    272. Anton RF, Ballenger JC, Lydiard RB, Laraia MT, Howell EF, Gold PW. CSF prostaglandin-E in agoraphobia with panic attacks. Biol Psychiatry. 1989 Jul; 26(3):257-64. PMID: 2545288.
      View in: PubMed
    273. Malcolm R, Ballenger JC, Sturgis ET, Anton R. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21. PMID: 2653057.
      View in: PubMed
    274. Kathol RG, Anton R, Noyes R, Gehris T. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol Psychiatry. 1989 Apr 01; 25(7):873-8. PMID: 2720002.
      View in: PubMed
    275. Brady KT, Anton RF. The thyroid axis and desipramine treatment in depression. Biol Psychiatry. 1989 Mar 15; 25(6):703-9. PMID: 2493818.
      View in: PubMed
    276. Becker HC, Anton RF. The benzodiazepine receptor inverse agonist RO15-4513 exacerbates, but does not precipitate, ethanol withdrawal in mice. Pharmacol Biochem Behav. 1989 Jan; 32(1):163-7. PMID: 2543989.
      View in: PubMed
    277. Randall CL, Anton RF, Becker HC, White NM. Role of prostaglandins in alcohol teratogenesis. Ann N Y Acad Sci. 1989; 562:178-82. PMID: 2742275.
      View in: PubMed
    278. Anton RF, Randall CL, Becker HC. PGE measurement in mouse embryos and uterine/embryo tissue. Prostaglandins. 1988 Dec; 36(6):835-46. PMID: 3244834.
      View in: PubMed
    279. Victoire C, Haag-Berrurier M, Lobstein-Guth A, Balz JP, Anton R. Isolation of Flavonol Glycosides from Ginkgo biloba Leaves. Planta Med. 1988 Jun; 54(3):245-7. PMID: 17265263.
      View in: PubMed
    280. Randall CL, Anton RF, Becker HC. Role of alcohol-induced hypothermia in mediating the teratogenic effects of alcohol in C57BL/6J mice. Alcohol Clin Exp Res. 1988 Jun; 12(3):412-6. PMID: 3044172.
      View in: PubMed
    281. Brown ME, Anton RF, Malcolm R, Ballenger JC. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry. 1988 Mar 01; 23(5):507-14. PMID: 3345323.
      View in: PubMed
    282. Anton R. Flavonoids and traditional medicine. Prog Clin Biol Res. 1988; 280:423-39. PMID: 3174704.
      View in: PubMed
    283. Becker HC, Anton RF, Randall CL. Stereotypic wall climbing in mice during ethanol withdrawal: a new measure of physical dependence. Alcohol. 1987 Nov-Dec; 4(6):443-7. PMID: 3435633.
      View in: PubMed
    284. Assaf MH, Ali AA, Makboul MA, Beck JP, Anton R. Preliminary study of phenolic glycosides from Origanum majorana; quantitative estimation of arbutin; cytotoxic activity of hydroquinone. Planta Med. 1987 Aug; 53(4):343-5. PMID: 3671554.
      View in: PubMed
    285. Randall CL, Anton RF, Becker HC. Effect of indomethacin on alcohol-induced morphological anomalies in mice. Life Sci. 1987 Jul 20; 41(3):361-9. PMID: 3600183.
      View in: PubMed
    286. Anton RF, Randall CL. Central nervous system prostaglandins and ethanol. Alcohol Clin Exp Res. 1987 Feb; 11(1):10-8. PMID: 3105343.
      View in: PubMed
    287. Randall CL, Anton RF, Becker HC. Alcohol, pregnancy, and prostaglandins. Alcohol Clin Exp Res. 1987 Feb; 11(1):32-6. PMID: 3551661.
      View in: PubMed
    288. Anton RF. Urinary free cortisol in psychotic depression. Biol Psychiatry. 1987 Jan; 22(1):24-34. PMID: 3790638.
      View in: PubMed
    289. Archipoff G, Linder C, Lobstein-Guth A, Anton R. Bioconversion of Morphine by Cell Suspensions of Ginkgo biloba Growing in vitro. Planta Med. 1986 Dec; (6):515-6. PMID: 17345446.
      View in: PubMed
    290. Roth A, Kuballa B, Bounthanh C, Cabalion P, Sévenet T, Beck JP, Anton R. Cytotoxic activity of polyindoline alkaloids of Psychotria forsteriana (Rubiaceae) (1). Planta Med. 1986 Dec; (6):450-3. PMID: 3494261.
      View in: PubMed
    291. Adjibade Y, Kuballa B, Cabalion P, Anton R. A New Alkaloid from Psychotria forsteriana. Planta Med. 1986 Dec; (6):523. PMID: 17345462.
      View in: PubMed
    292. Anton RF, Waid LR, Fossey M, AuBuchon P. Case report of carbamazepine treatment of organic brain syndrome with psychotic features. J Clin Psychopharmacol. 1986 Aug; 6(4):232-4. PMID: 3734143.
      View in: PubMed
    293. Weniger B, Rouzier M, Daguilh R, Foucaud J, Robineau L, Anton R. [Traditional medicine in the Central Plateau of Haiti. 1. Study of the traditional therapeutic system in a rural socio-cultural area]. J Ethnopharmacol. 1986 Jul; 17(1):1-11. PMID: 3762192.
      View in: PubMed
    294. Weniger B, Rouzier M, Daguilh R, Henrys D, Henrys JH, Anton R. [Traditional medicine in the Central Plateau of Haiti. 2. Ethnopharmacologic inventory]. J Ethnopharmacol. 1986 Jul; 17(1):13-30. PMID: 3762193.
      View in: PubMed
    295. Becker HC, Randall CL, Anton RF. Pre-pregnancy alcohol experience attenuates typical decrease in gestational alcohol consumption in mice. Alcohol. 1986 Jan-Feb; 3(1):19-22. PMID: 3964433.
      View in: PubMed
    296. Becker HC, Anton RF, De Trana C, Randall CL. Sensitivity to ethanol in female mice: effects of ovariectomy and strain. Life Sci. 1985 Oct 07; 37(14):1293-300. PMID: 4046734.
      View in: PubMed
    297. Johnson GC, Anton RF. Delusions of parasitosis: differential diagnosis and treatment. South Med J. 1985 Aug; 78(8):914-8. PMID: 4023781.
      View in: PubMed
    298. Anton RF, Paladino JA, Morton A, Thomas RW. Effect of acute alcohol consumption on lithium kinetics. Clin Pharmacol Ther. 1985 Jul; 38(1):52-5. PMID: 4006376.
      View in: PubMed
    299. Randall CL, Anton RF. Aspirin reduces alcohol-induced prenatal mortality and malformations in mice. Alcohol Clin Exp Res. 1984 Nov-Dec; 8(6):513-5. PMID: 6393800.
      View in: PubMed
    300. Wallis CJ, Anton RF, Randall CL. Adrenalectomy reduces alcohol-stimulated activity: blood and brain alcohol content. Pharmacol Biochem Behav. 1984 Jun; 20(6):883-6. PMID: 6540448.
      View in: PubMed
    301. Briançon-Scheid F, Lobstein-Guth A, Anton R. HPLC Separation and Quantitative Determination of Biflavones in Leaves from Ginkgo biloba. Planta Med. 1983 Dec; 49(12):204-7. PMID: 17405053.
      View in: PubMed
    302. Bounthanh C, Richert L, Beck JP, Haag-Berrurier M, Anton R. The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells. Planta Med. 1983 Nov; 49(3):138-42. PMID: 6657786.
      View in: PubMed
    303. Anton RF, Sexauer JD, Randall CL. Amoxapine elevates serum prolactin in depressed men. J Affect Disord. 1983 Nov; 5(4):305-10. PMID: 6229562.
      View in: PubMed
    304. Anton RF, Sexauer JD. Efficacy of amoxapine in psychotic depression. Am J Psychiatry. 1983 Oct; 140(10):1344-7. PMID: 6624968.
      View in: PubMed
    305. Anton RF, Wallis C, Randall CL. In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins. 1983 Sep; 26(3):421-9. PMID: 6658001.
      View in: PubMed
    306. Johnson GC, Anton RF. Pimozide in delusions of parasitosis. J Clin Psychiatry. 1983 Jun; 44(6):233. PMID: 6853463.
      View in: PubMed
    307. Anton RF, Randall CL, Williams CK, Hoffmeyer GE. Inhibition of prostaglandin synthesis by indomethacin does not affect alcohol consumption in inbred mice. Alcohol Clin Exp Res. 1983; 7(4):386-8. PMID: 6362463.
      View in: PubMed
    308. Randall CL, Hughes SS, Williams CK, Anton RF. Effect of prenatal alcohol exposure on consumption of alcohol and alcohol-induced sleep time in mice. Pharmacol Biochem Behav. 1983; 18 Suppl 1:325-9. PMID: 6685299.
      View in: PubMed
    309. Murburg M, Anton RF, Nelson JC, Jatlow PI. Noninvasive measurement of cardiac ejection fraction during desipramine treatment. Psychosomatics. 1982 Jul; 23(7):759-61. PMID: 7122806.
      View in: PubMed
    310. Weniger B, Haag-Berrurier M, Anton R. Plants of Haiti used as antifertility agents. J Ethnopharmacol. 1982 Jul; 6(1):67-84. PMID: 7109665.
      View in: PubMed
    311. Anton RF, Hogan I, Jalali B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug Alcohol Depend. 1981 Sep; 8(2):157-68. PMID: 7318681.
      View in: PubMed
    312. Guth A, Briançon-Scheid F, Haag-Berrurier M, Anton R. [Analyse qualitative et quantitative des terpènes de Ginkgo biloba par HPLC.]. Planta Med. 1981 Jun; 42(6):129-30. PMID: 17401929.
      View in: PubMed
    313. Bounthanh C, Bergmann C, Beck JP, Haag-Berrurier M, Anton R. Valepotriates, a new class of cytotoxic and antitumor agents. Planta Med. 1981 Jan; 41(1):21-8. PMID: 7232547.
      View in: PubMed
    314. Anton RF. Linoleic acid in the treatment of lithium toxicity and familial tremor. Prostaglandins Med. 1980 Oct; 5(4):321-2. PMID: 7443876.
      View in: PubMed
    315. Schroeder G, Rohmer M, Beck JP, Anton R. Cytotoxic activity of 6,20-epoxylathyrol and its aliphatic diesters. Planta Med. 1979 Mar; 35(3):235-41. PMID: 432301.
      View in: PubMed
    Anton's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _